References
- International Diabetes Federation. Diabetes Facts & figures [Internet]. 2020. [cited 2020 Aug]. Available from: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html
- MINSAL. ENCUESTA NACIONAL DE SALUD 2016-2017 [Internet]. 2017. [cited 2020 Aug]. Available from: https://www.minsal.cl/wp-content/uploads/2017/11/ENS-2016-17_PRIMEROS-RESULTADOS.pdf
- Henderson JN, K V A, Deary IJ, et al. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003 Dec;20(12):1016–1021.
- Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med. Internet. 2005 Jun 1;22(6):749–755.
- Graveling AJ, Frier BM. Hypoglycaemia: an overview. Prim Care Diabetes. 2009 Aug;3(3):131–139.
- Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. Internet. 2010 Oct 6;363(15):1410–1418.
- Phung OJ, Scholle JM, Talwar M, et al. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA. Internet. 2010 Apr 14;303(14):1410–1418. .
- MINSAL. Guía Clínica DM II [Internet]. 2010. [cited 2020 Aug]. Available from: https://www.minsal.cl/portal/url/item/72213ed52c3e23d1e04001011f011398.pdf
- Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3. Value Heal. Internet. 2012 Sep 1;15(6):812–820.
- Schroeder EB, Xu S, Goodrich GK, et al. Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: development and external validation of a prediction model. J Diabetes Complications. Internet]. 2017;31(7):1158–1163. Available from: http://www.sciencedirect.com/science/article/pii/S1056872717302957
- Edridge CL, Dunkley AJ, Bodicoat DH, et al. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One. Internet. 2015 Jun 10;10(6):e0126427.
- Boulin M, Diaby V, Tannenbaum C. Preventing unnecessary costs of drug-induced hypoglycemia in older adults with type 2 diabetes in the United States and Canada. PLoS One. Internet. 2016 Sep 20;11(9):e0162951. .
- Instituto Nacional de Estadísticas. Índice de Precios al Consumidor (IPC) [Internet]. 2020. [cited 2020 Aug]. Available from: https://calculadoraipc.ine.cl/
- Banco Central. Base de datos estadísticos [Internet]. 2020. [cited 2020 Aug]. Available from: https://si3.bcentral.cl/Bdemovil/BDE/Series/MOV_SC_TC1
- Quilliam BJ, Simeone JC, Ozbay AB, et al. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care. 2011 Oct;17(10):673–680.
- Núñez M, Díaz S, Dilla T, et al. Epidemiology, quality of life, and costs associated with hypoglycemia in patients with diabetes in Spain: a systematic literature review. [Internet]. Diabetes Ther. 2019;10(2):375–392.
- Holstein A, Plaschke A, Egberts E-H. Incidence and Costs of Severe Hypoglycemia. Diabetes Care. [Internet]. 2002 Nov 1;25(11):2109LP– 2110. Available from: http://care.diabetesjournals.org/content/25/11/2109.abstract
- Aljunid SM, Aung YN, Ismail A, et al. Economic burden of hypoglycemia for type II diabetes mellitus patients in Malaysia. PLoS One. [Internet]. 2019 Oct 25;14(10):e0211248.
- Mahoney GK, Henk HJ, McCoy RG. Severe hypoglycemia attributable to intensive glucose-lowering therapy among US adults with diabetes: population-based modeling study, 2011-2014. Mayo Clin Proc. 2019 Sep;94(9):1731–1742.
- S V A, Lipska KJ, Wang J, et al. Use of intensive glycemic management in older adults with diabetes mellitus. J Am Geriatr Soc. 2018 Jul;66(6):1190–1194.
- Einarson TR, Acs A, Ludwig C, et al. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Heal J Int Soc Pharmacoecon Outcomes Res. 2018 Jul;21(7):881–890.
- Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ global health. 2019;4(1):e001258.
- Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015 Aug;33(8):811–831.
- Owolabi MO, Yaria JO, Daivadanam M, et al. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care. 2018 May;41(5):1097–1105.
- O’Reilly DJ, Burke N, Tarride J-E, et al. Direct health-care costs and productivity costs associated with hypoglycemia in adults with type 1 and type 2 diabetes mellitus that participated in the canadian hypoglycemia assessment tool program. Can J Diabetes. Internet. 2018 Dec 1;42(6):659–663.
- Jönsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with type 2 diabetes in Sweden. Value Heal. Internet]. 2006;9(3):193–198. Available from: http://www.sciencedirect.com/science/article/pii/S1098301510643136